NEW YORK, Jan. 14, 2016 /PRNewswire/ --
What can be expected from the ophthalmic devices market? Which areas are going to grow at the fastest rates? Visiongain's brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.
Our 205-page report provides 176 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. You will see financial results, interviews, trends, opportunities, and revenue predictions.
Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter's Five Forces analysis), product profiles and commercial developments. Read the full transcripts of two exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales, including:
- Ellie Bai, Press Relations Officer, Taiwan Liposome Company
- Martina Iniotri, Ophthalmic Specialist, JINS Eyewear Inc.
See revenue forecasts for the leading international markets
How will leading national markets perform to 2025? Our study forecasts ophthalmic device revenues in national markets, including:
- Rest of Europe
- Rest of the World
Leading companies and potential for market growth
Overall world revenue for ophthalmic devices market will reach $18bn in 2015, our work forecasts. We predict strong revenue growth through to 2025. The ageing population in many of the world's largest markets will combine with a shift towards newer and more expensive lenses which will drive sales to 2025.
Our work analyses the key companies in the market. See visiongain's analysis of 10 leading ophthalmic device companies, including these:
- Johnson and Johnson
- Alcon (Novartis)
- Bausch and Lomb (Valeant)
- Abbot Medical
- Hoya Corporation
- Carl Zeiss Meditec
- Nidek Co.
- STAAR Surgical
A company profile gives you the following information where available:
- Historical revenues from 2013 to 2014
- Discussion of a company's activities and outlook
- Recent financial results
- Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborations, including alliances, partnerships and joint ventures
Discover capabilities, progress, and commercial prospects, helping you stay ahead.
Research and development - assess innovation, trends and possibilities
What about R&D – the pipeline for new devices? You see trends for these areas and technologies:
- Smart Lens technology
- Ocular drug delivery devices
- Highly efficient surgical devices and suites
The R&D pipeline for surgical devices is particularly strong, with faster and more precise machines being in demand. These are not revolutions in the technology and may not allow for new surgeries to be performed, but instead increase the efficiency of current surgeries.
What issues will affect the ophthalmic devices industry?
Our new report discusses issues and events affecting the ophthalmic devices market. You will find discussions, including qualitative analyses:
- Highly challenging payment environment
- Rapidly advancing technology leading to quickly eroding profit margins
- The rise of pharmaceutical treatments for a number of ophthalmic diseases
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and busines
Read the full report: http://www.reportlinker.com/p03247301-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001